Current Neuro-Oncology
Volume
11 Number 1
31 January 2009
Home > Publications > Current Neuro-Oncology > Volume 11, Year 2009 > Number 1, 31 January
Levner I, Drabycz S, Roldan G, De
Robles P, Cairncross JG, Mitchell R.
Predicting
MGMT methylation status of glioblastomas from MRI texture.
Med
Image Comput Comput Assist Interv.
2009;12(Pt 2):522-30. doi:
10.1007/978-3-642-04271-3_64. PMID:
20426152. Observational
study.
ˍ
Riina HA, Fraser JF, Fralin S,
Knopman J, Scheff RJ, Boockvar JA.
Superselective
intraarterial cerebral infusion of bevacizumab: a revival of
interventional
neuro-oncology for malignant glioma.
J
Exp Ther Oncol. 2009;8(2):145-50.
PMID:
20192120. Case report˰
ˍ
Agrawal A.
Butterfly
glioma of the corpus callosum.
J
Cancer Res Ther.
2009 Jan-Mar;5(1):43-5. doi:
10.4103/0973-1482.48769. PMID:
19293489. Case report. ˍ
Al-Barbarawi MM, Qudsieh SM,
Ghazzawi MA, Smith SF.
Glioblastoma
multiforme of the cerebellum.
Neurosciences
(Riyadh). 2009 Jan;14(1):84-8.
PMID:
21048582. Case report. ˍ
McGirt
MJ, Chaichana KL, Gathinji M, Attenello FJ, Than K, Olivi A,
Weingart JD, Brem H, Quiñones-Hinojosa AR.
Independent
association of extent of resection with survival in patients with
malignant brain astrocytoma.
J
Neurosurg.
2009 Jan;110(1):156-62. doi:
10.3171/2008.4.17536. PMID:
18847342. Observational study.
ˍ
Aghi
MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza
RL, Curry WT Jr, Barker FG 2nd.
Long-term
recurrence rates of atypical meningiomas after gross total
resection with or without postoperative adjuvant
radiation.
Neurosurgery.
2009 Jan 1;64(1):56-60. doi:
10.1227/01.NEU.0000330399.55586.63. PMID:
19145156. Observational study.
ˍ
Campos S, Davey P, Hird A,
Pressnail B, Bilbao J, Aviv RI, Symons S, Pirouzmand
F, Sinclair E, Culleton S, Desa E, Goh P, Chow E.
Brain
metastasis from
an unknown primary, or primary brain tumour?
A
diagnostic dilemma.
Curr
Oncol.
2009 Jan 1;16(1):62-6. doi:
10.3747/co.v16i1.308.
PMID:
19229374. Case report. ˍ
Loja
T, Chlapek P, Kuglik P, Pesakova M, Oltova A, Cejpek P, Veselska
R.
Characterization
of a GM7 glioblastoma cell line showing CD133 positivity and both
cytoplasmic and nuclear localization of nestin.
Oncol
Rep.
2009 Jan 1;21(1):119-27. doi:
10.3892/or_00000198. PMID:
19082452. Laboratory investigation.
ˍ
Park CK, Park SH, Lee SH, Kim CY,
Kim DW, Paek SH, Kim DG, Heo DS, Kim IH, Jung HW.
Methylation
status of the MGMT gene promoter fails to predict the clinical
outcome of glioblastoma patients treated with ACNU plus
cisplatin.
Neuropathology.
2009 Jan 6;29(4):443-9. doi:
10.1111/j.1440-1789.2008.00998.x. PMID:
19170894. Observational
study.
ˍ
Derr RL, Ye X, Islas MU, Desideri
S, Saudek CD, Grossman SA.
Association
between hyperglycemia and survival in patients with newly
diagnosed glioblastoma.
J
Clin Oncol. 2009
Jan 12;27(7):1082-6. doi:
10.1200/JCO.2008.19.1098. PMID:
19139429. Interventional study. ˍ
Ertan Y, Sezak M, Demirağ B,
Kantar M, Cetingül N, Turhan T, Erşahin Y, Mutluer S,
Anacak Y, Akalin T.
Medulloblastoma:
clinicopathologic evaluation of 42 pediatric cases.
Childs
Nerv Syst. 2009
Jan 13;25(3):353-6. doi:
10.1007/s00381-008-0784-4. PMID:
19139904. Observational
study.
ˍ
Lesimple T, Riffaud L, Frappaz D,
Ben Hassel M, Gédouin D, Bay JO, Linassier C, Hamlat A,
Piot G, Fabbro M, Saïkali S, Carsin B, Guégan
Y.
Topotecan
in combination with radiotherapy in unresectable glioblastoma: a
phase 2 study.
J
Neurooncol. 2009
Jan 13;93(2):253-60. doi:
10.1007/s11060-008-9774-3. PMID:
19139825. Interventional study. ˍ
*
Torcuator R, Zuniga R, Loutfi R,
Mikkelsen T.
Bevacizumab
and irinotecan treatment for progressive diffuse brainstem glioma:
case report.
J
Neurooncol. 2009
Jan 13;93(3):409-12. doi:
10.1007/s11060-008-9782-3. PMID:
19139822. Case report. ˍ
Watkins JM, Marshall DT, Patel S,
Giglio P, Herrin AE, Garrett-Mayer E, Jenrette JM 3rd.
High-dose
radiotherapy to 78 Gy with or without temozolomide for high grade
gliomas.
J
Neurooncol. 2009
Jan 14;93(3):343-8. doi:
10.1007/s11060-008-9779-y. PMID:
19142584. Observational
study.
ˍ
Broniscer A, Baker SJ, Stewart CF,
Merchant TE, Laningham FH, Schaiquevich P, Kocak M, Morris EB,
Endersby R, Ellison DW, Gajjar A.
Phase
I and pharmacokinetic studies of erlotinib administered
concurrently with radiotherapy for children, adolescents, and
young adults with high-grade glioma.
Clin
Cancer Res. 2009
Jan 15;15(2):701-7. doi:
10.1158/1078-0432.CCR-08-1923. PMID:
19147777. Interventional study. ˍ
Biassoni V, Pallotti F, Spreafico
F, Seregni E, Gandola L, Martinetti A, Bombardieri E, Massimino
M.
A
female survivor of childhood medulloblastoma presenting with
growth-hormone-induced edema and inflammatory lesions: a case
report.
J
Med Case Rep.
2009 Jan 16;3:17. doi:
10.1186/1752-1947-3-17. PMID:
19149892. Case report. ˍ
McGregor LM, Spunt SL, Santana VM,
Stewart CF, Ward DA, Watkins A, Laningham FH, Ivy P, Furman WL,
Fouladi M.
Phase
1 study of an oxaliplatin and etoposide regimen in pediatric
patients with recurrent solid tumors.
Cancer.
2009 Jan 20;115(3):655-64. doi:
10.1002/cncr.24054. PMID:
19117350. Interventional study. ˍ
Arulrajah S, Huisman TA.
Pilomyxoid
astrocytoma of the spinal cord with cerebrospinal fluid and
peritoneal metastasis.
Neuropediatrics.
2009 Jan 22;39(4):243-5. doi:
10.1055/s-0028-1103273. PMID:
19165714. Case report. ˍ
Koga T, Morita A, Maruyama K,
Tanaka M, Ino Y, Shibahara J, Louis DN, Reifenberger G, Itami J,
Hara R, Saito N, Todo T.
Long-term
control of disseminated pleomorphic xanthoastrocytoma with
anaplastic features by means of stereotactic irradiation.
Neuro
Oncol. 2009 Jan
22;11(4):446-51. doi:
10.1215/15228517-2008-112. PMID:
19164434. Case report. ˍ
Laks DR, Masterman-Smith M, Visnyei
K, Angenieux B, Orozco NM, Foran I, Yong WH, Vinters HV, Liau LM,
Lazareff JA, Mischel PS, Cloughesy TF, Horvath S, Kornblum
HI.
Neurosphere
formation is an independent predictor of clinical outcome in
malignant glioma.
Stem
Cells. 2009 Jan
22;27(4):980-7. doi:
10.1002/stem.15. PMID:
19353526. Observational
study.
ˍ
Packer RJ, Jakacki R, Horn M, Rood
B, Vezina G, MacDonald T, Fisher MJ, Cohen B.
Objective
response of multiply recurrent low-grade gliomas to bevacizumab
and irinotecan.
Pediatr
Blood Cancer.
2009 Jan 22;52(7):791-5. doi:
10.1002/pbc.21935. PMID:
19165892. Observational
study.
ˍ
Pietilä S, Mäkipernaa A,
Sievänen H, Koivisto AM, Wigren T, Lenko HL.
Obesity
and metabolic changes are common in young childhood brain tumor
survivors.
Pediatr
Blood Cancer.
2009 Jan 22;52(7):853-9. doi:
10.1002/pbc.21936. PMID:
19165891. Observational
study.
ˍ
Gutin PH, Iwamoto FM, Beal K,
Mohile NA, Karimi S, Hou BL, Lymberis S, Yamada Y, Chang J, Abrey
LE.
Safety
and efficacy of bevacizumab with hypofractionated stereotactic
irradiation for recurrent malignant gliomas.
Int
J Radiat Oncol Biol Phys.
2009 Jan 23;75(1):156-63. doi:
10.1016/j.ijrobp.2008.10.043. PMID:
19167838. Observational
study.
ˍ
Brandes AA, Tosoni A, Franceschi E,
Blatt V, Santoro A, Faedi M, Amistà P, Gardiman M, Labianca
R, Bianchini C, Ermani M, Reni M.
Fotemustine
as second-line treatment for recurrent or progressive glioblastoma
after concomitant and/or adjuvant temozolomide: a phase II trial
of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
Cancer
Chemother Pharmacol.
2009 Jan 24;64(4):769-75. doi:
10.1007/s00280-009-0926-8. PMID:
19169684. Interventional study. ˍ
Lim DA, Tarapore P, Chang E, Burt
M, Chakalian L, Barbaro N, Chang S, Lamborn KR, McDermott
MW.
Safety
and feasibility of switching from phenytoin to levetiracetam
monotherapy for glioma-related seizure control following
craniotomy: a randomized phase II pilot study.
J
Neurooncol. 2009
Jan 24;93(3):349-54. doi:
10.1007/s11060-008-9781-4. PMID:
19169651. Interventional study. ˍ
Nishi N, Kawai S, Yonezawa T,
Fujimoto K, Masui K.
Early
appearance of high grade glioma on magnetic resonance
imaging.
Neurol
Med Chir (Tokyo).
2009 Jan 25;49(1):8-12. doi:
10.2176/nmc.49.8. PMID:
19168996. Observational
study.
ˍ
*
Rosati A, Tomassini A, Pollo B,
Ambrosi C, Schwarz A, Padovani A, Bonetti B.
Epilepsy
in cerebral glioma: timing of appearance and histological
correlations.
J
Neurooncol. 2009
Jan 29;93(3):395-400. doi:
10.1007/s11060-009-9796-5. PMID:
19183850. Observational
study.
ˍ
Johnston DL, Keene D, Bartels U,
Carret AS, Crooks B, Eisenstat DD, Fryer C, Lafay-Cousin L,
Larouche V, Moghrabi A, Wilson B, Zelcer S, Silva M, Brossard J,
Bouffet E.
Medulloblastoma
in children under the age of three years: a retrospective Canadian
review.
J
Neurooncol. 2009
Jan 31;94(1):51-6. doi:
10.1007/s11060-009-9799-2. PMID:
19184579. Observational
study.
ˍ